influenza
viru
respiratori
pathogen
respons
influenza
infect
pandem
influenza
viru
caus
sever
lower
airway
inflamm
pneumonia
asthma
chronic
inflammatori
disord
airway
affect
entir
brachial
tree
one
commonest
underli
medic
condit
among
patient
hospit
pandem
influenza
viru
infect
although
respiratori
viru
infect
major
caus
asthma
exacerb
mechan
influenza
exacerb
asthma
poorli
understood
anim
model
diseas
comorbid
crucial
understand
hostpathogen
interact
elucid
complex
patholog
exist
murin
model
influenza
viru
infect
asthmat
show
asthmat
mice
highli
resist
influenza
viru
infect
contradict
clinic
observ
human
develop
murin
model
influenza
virusasthma
comorbid
use
ncnga
mice
highli
sensit
allerg
reaction
atop
dermat
allerg
airway
inflamm
model
use
examin
impact
allerg
airway
inflamm
lung
patholog
pandem
influenza
viru
infect
mice
result
show
induct
acut
allerg
airway
inflamm
preexist
influenza
viru
infect
addit
effect
exacerb
lung
patholog
mirror
find
human
epidemiolog
studi
contrast
preexist
allerg
airway
inflamm
protect
subsequ
influenza
viru
infect
compat
previou
murin
model
influenza
viru
infect
asthmat
mice
variabl
outcom
murin
model
indic
tempor
relat
allerg
airway
inflamm
influenza
viru
infect
might
play
critic
role
asthma
influenza
comorbid
thu
murin
model
understand
influenza
viru
infect
affect
asthmat
host
may
aid
develop
strategi
improv
treatment
outcom
asthmat
harbor
influenza
viru
infect
et
al
impact
allerg
airway
inflamm
lung
patholog
mous
model
influenza
viru
infect
plo
one
formal
analysi
ak
ts
fund
acquisit
ts
hh
investig
ak
ts
yo
kt
ys
aa
nn
methodolog
ak
ts
aa
nn
project
administr
ts
mt
hh
resourc
ak
ts
ys
aa
mt
supervis
mt
hh
novel
comorbid
mous
model
asthma
influenza
plo
one
introduct
influenza
viru
etiolog
agent
influenza
character
sudden
onset
high
fever
respiratori
symptom
cough
sore
throat
well
system
symptom
headach
muscl
ach
fatigu
influenza
virus
continu
circul
human
popul
worldwid
annual
epidem
result
approxim
three
five
million
case
sever
ill
approxim
death
influenza
pandem
caus
novel
tripl
reassort
influenza
viru
first
emerg
pig
mexico
spread
rapidli
across
globe
pandem
influenza
occasion
caus
sever
lower
airway
inflamm
pneumonia
among
patient
pandem
influenza
viru
infect
note
asthma
common
comorbid
among
patient
hospit
influenza
pandem
asthma
chronic
inflammatori
airway
disord
affect
entir
brachial
tree
distress
million
peopl
worldwid
make
major
public
health
concern
inhal
specif
allergen
environment
materi
asthma
induc
acut
airway
hypersensit
smooth
muscl
contract
mucos
edema
mucu
hypersecret
result
airway
obstruct
caus
symptom
includ
cough
wheez
chest
tight
airway
obstruct
variabl
symptomfre
period
interspers
period
repeat
exacerb
respiratori
viru
infect
common
caus
asthma
exacerb
viru
commonli
associ
asthma
exacerb
rhinoviru
follow
coronaviru
respiratori
syncyti
viru
parainfluenza
viru
influenza
viru
anim
model
human
infecti
diseas
crucial
role
elucid
pathogenesi
develop
prevent
treatment
infecti
diseas
similar
human
diseas
phenotyp
anim
model
phenotyp
critic
factor
elucid
pathogenesi
human
diseas
howev
suscept
anim
human
pathogen
differ
significantli
depend
anim
speci
strain
phenotyp
infecti
diseas
anim
model
may
differ
slightli
human
diseas
requir
care
interpret
anim
model
phenotyp
exist
murin
model
asthma
respiratori
viru
infect
shown
influenza
virus
involv
asthma
develop
howev
murin
model
develop
examin
pathogenesi
influenzaallerg
asthma
show
asthmat
mice
highli
resist
influenza
viru
infect
contradict
find
epidemiolog
studi
human
impli
studi
use
anim
model
need
elucid
pathogenesi
complic
comorbid
influenza
viru
infect
asthmat
ovalbumin
ova
sensit
ovachalleng
murin
model
base
balbc
mice
one
popular
proven
model
allerg
airway
inflamm
howev
often
difficult
reproduc
complic
clinic
set
faith
anim
model
use
inbr
laboratori
mice
strain
differ
laboratori
strain
mice
show
differ
suscept
respons
antigen
inbr
strain
laboratori
mice
ncnga
use
anim
model
human
atop
dermat
harbor
mutat
chromosom
link
increas
ige
product
increas
respons
repeat
administr
allergen
skin
mice
induc
atop
dermatitislik
skin
lesion
happen
balbc
mice
moreov
massiv
prolong
allerg
respons
eosinophil
infiltr
ige
product
sever
airway
inflamm
observ
ovasensit
ovachalleng
ncnga
mice
balbc
mice
indic
ncnga
mice
sensit
sever
type
allerg
diseasereact
includ
allerg
airway
inflamm
balbc
mice
develop
influenza
virusinfectionatop
mous
comorbid
model
base
ncnga
mice
pandem
influenza
viru
use
mous
model
investig
impact
allergen
challeng
lung
patholog
pandem
influenza
viru
infect
mice
observ
acut
allerg
inflamm
airway
asthmat
mice
soon
influenza
viru
infect
enhanc
pulmonari
inflamm
subsequ
epitheli
goblet
cell
metaplasia
weight
loss
without
affect
viru
replic
rais
hypothesi
allergen
challeng
top
influenza
viru
infect
induc
inflamm
addit
effect
exacerb
lung
tissu
damag
find
compat
previou
human
clinic
observ
contrast
preexist
allerg
airway
inflamm
inhibit
subsequ
influenza
viru
infect
consist
previou
murin
model
influenzaallerg
asthma
two
differ
outcom
murin
model
suggest
tempor
relat
influenza
viru
infect
allerg
airway
inflamm
might
one
determin
comorbid
influenza
viru
infect
asthmat
thu
murin
model
contribut
understand
influenza
viru
exacerb
enhanc
airway
patholog
asthmat
host
anim
ncnga
mice
femal
week
old
bred
specif
pathogenfre
condit
purchas
japan
slc
inc
shizuoka
japan
anim
studi
perform
strict
accord
guidelin
proper
conduct
anim
experi
scientif
council
japan
anim
experi
conduct
strict
complianc
anim
husbandri
welfar
regul
handl
biosafeti
level
two
anim
facil
accord
guidelin
anim
care
use
committe
nation
institut
infecti
diseas
approv
committe
approv
no
mice
monitor
daili
clinic
sign
morbid
mortal
day
post
infect
human
endpoint
use
mice
lost
initi
bodi
weight
studi
anim
met
criteria
score
dead
euthan
excess
isofluran
anesthesia
accord
institut
guidelin
mouseadapt
influenza
viru
obtain
passag
mice
use
repres
viru
studi
viru
grown
allanto
caviti
fertil
chicken
egg
mice
infect
via
intranas
administr
pb
contain
viru
suspens
plaqueform
unit
pfu
mous
left
nostril
viru
titer
measur
accord
method
tobita
et
al
briefli
aliquot
bronchoalveolar
lavag
fluid
balf
serial
dilut
inocul
mdck
cell
sixwel
plate
h
well
wash
remov
nonattach
viru
overlaid
ml
agar
medium
number
plaqu
count
crystal
violet
stain
day
postinocul
viru
titer
express
pfuml
ncnga
mous
model
ovainduc
allerg
airway
inflamm
use
studi
slight
modif
six
eight
week
old
femal
ncnga
mice
sensit
two
consecut
weekli
intraperiton
ip
inject
ova
sigmaaldrich
st
loui
mo
plu
mg
alum
crystal
invivogen
san
diego
ca
one
week
second
ip
sensit
mice
anesthet
intraperiton
inject
mixtur
mg
ketamin
mg
xylazin
g
bodi
weight
subject
challeng
viru
control
mock
noninfect
mice
inocul
dilut
allanto
fluid
lack
viru
follow
day
virusinfect
mice
anesthet
intraperiton
inject
mixtur
mg
ketamin
mg
xylazin
g
bodi
weight
challeng
ova
pb
control
mice
allerg
airway
inflamm
challeng
pb
instead
ova
noninfect
mice
mice
per
group
mice
mice
per
group
monitor
weight
loss
balf
harvest
deliv
ml
pb
lung
tracheal
cannula
number
type
cell
viru
titer
level
cytokin
chemokin
balf
measur
number
cell
balf
count
use
vetscan
abaxi
veterinari
diagnost
union
citi
ca
confirm
morpholog
cell
balf
centrifug
onto
glass
slide
rpm
min
use
shandon
cytocentrifug
thermo
fisher
scientif
inc
waltham
cell
stain
giemsa
analyz
microscopi
rest
balf
centrifug
min
g
remov
cell
debri
store
requir
level
inflammatori
cytokineschemokin
balf
measur
use
mous
cytokin
twentyplex
antibodi
bead
kit
invitrogen
san
diego
ca
dilut
balf
analyt
describ
manufactur
assay
determin
concentr
follow
cytokin
chemokin
granulocytemacrophag
colonystimul
factor
gmcsf
gamma
interferon
interleukin
gamma
interferoninduc
protein
fibroblast
growth
factorbas
fgfbasic
neutrophilrel
chemokin
kc
kc
gro
monocyt
chemoattract
protein
macrophag
inflammatori
protein
monokin
induc
gamma
interferon
tumor
necrosi
factor
alpha
vascular
endotheli
growth
factor
vegf
type
ifn
balf
measur
use
mous
alpha
beta
ifn
enzymelink
immunosorb
assay
elisa
kit
pbl
interferon
sourc
piscataway
nj
accord
protocol
describ
manufactur
experi
involv
neuraminidas
inhibitor
treatment
mous
duoset
elisa
r
system
inc
minneapoli
mn
use
measur
concentr
anim
sacrif
day
day
postinfect
excis
lung
tissu
fix
phosphatebuff
formalin
inject
trachea
lung
inflat
lobe
fix
lung
tissu
embed
paraffin
section
stain
hematoxylin
eosin
h
e
period
acidschiff
pa
number
pa
posit
epitheli
cell
lung
tissu
obtain
visual
estim
entir
area
section
immunohistochemistri
perform
rabbit
polyclon
antibodi
type
influenza
nucleoprotein
iav
np
antigen
prepar
laboratori
primari
antibodi
previous
describ
peroxidaselabel
polymerconjug
antirabbit
immunoglobulin
envisionhrp
dako
glostrup
denmark
use
secondari
antibodi
peroxidas
activ
detect
diaminobenzidinehydrogen
peroxid
statist
analysi
perform
use
graphpad
prism
statist
softwar
packag
version
graph
pad
softwar
inc
ca
comparison
two
group
perform
use
unpair
student
ttest
mannwhitney
u
test
comparison
three
group
perform
use
oneway
anova
follow
tukey
multipl
comparison
test
nonparametr
oneway
anova
kruskalw
test
follow
dunn
multipl
comparison
test
analyz
data
two
independ
variabl
bodi
weight
measur
perform
use
twoway
anova
follow
sidak
multipl
comparison
test
data
consid
statist
signific
p
first
murin
model
allerg
airway
inflamm
set
examin
effect
preexist
influenza
viru
infect
subsequ
allerg
airway
inflamm
ncnga
mice
sensit
ova
model
allergen
repeat
ip
inject
aluminum
hydroxid
adjuv
sensit
mice
infect
subleth
dose
influenza
viru
subsequ
infect
mice
challeng
ova
two
consecut
day
fig
mice
exhibit
weight
loss
much
sever
mice
subject
ova
challeng
howev
noninfect
mice
without
ova
challeng
mockova
mockpb
respect
lose
weight
fig
howev
viral
titer
balf
mice
affect
ova
challeng
fig
allergen
challeng
respiratori
infect
induc
pulmonari
inflamm
although
differ
type
immun
cell
take
preced
reaction
histopatholog
analysi
reveal
lung
tissu
mice
show
massiv
infiltr
inflammatori
cell
includ
eosinophil
fig
left
panel
inset
bronchiol
alveoli
day
postinfect
fig
left
panel
contrast
lung
mice
show
limit
inflamm
perivascular
alveolar
area
fig
left
middl
panel
lung
mock
ova
mice
also
show
mild
eosinophil
inflamm
around
bronchiol
mockpb
mice
remain
intact
confirm
acut
allerg
airway
inflamm
induc
challeng
ova
rout
two
consecut
day
mice
fig
right
middl
right
panel
signific
increas
total
cell
number
proport
eosinophil
involv
acut
allerg
airway
inflamm
observ
balf
mice
day
postinfect
compar
balf
mice
fig
also
observ
balf
mockova
mice
compar
balf
mockpb
mice
fig
contrast
differ
proport
neutrophil
trigger
influenza
viru
infect
mice
signific
fig
taken
togeth
observ
indic
ovainduc
acut
allerg
airway
inflamm
upon
influenza
viru
infect
synergist
exacerb
lung
patholog
without
affect
influenza
viru
replic
virusinduc
neutrophil
inflamm
influenza
viru
infect
subsequ
acut
allerg
airway
respons
synergist
enhanc
chemokin
product
cytokin
chemokin
induc
viru
infect
allerg
respons
crucial
molecul
regul
inflamm
process
lung
concentr
correl
sever
ill
measur
amount
variou
cytokin
chemokin
balf
mice
found
express
significantli
higher
mockova
mice
mockpb
mice
furthermor
level
three
chemokin
mice
markedli
higher
three
group
fig
contrast
level
gmcsf
vegf
fig
fig
mice
higher
mice
level
cytokin
interferon
mice
higher
mockpb
mice
fig
observ
suggest
acut
allerg
immun
respons
airway
soon
influenza
viru
infect
synergist
effect
product
influenza
viru
infect
induc
immun
respons
chemokin
might
play
pivot
role
exacerb
pulmonari
inflamm
influenza
viru
infect
mice
subsequ
allergen
challeng
contrast
although
level
significantli
higher
mockova
mice
mockpb
mice
markedli
lower
mice
mockova
mice
fig
confirm
exacerb
lung
patholog
observ
model
might
attribut
synergist
increas
chemokin
product
induc
preexist
influenza
viru
infect
subsequ
allerg
airway
inflamm
deterior
acut
allerg
airway
inflamm
inflammatori
respons
recent
report
show
acut
allerg
airway
inflamm
acceler
clearanc
influenza
viru
appear
contradict
present
observ
explor
reason
appar
differ
modifi
experiment
protocol
revers
order
intervent
ncnga
mice
first
sensit
ova
repeat
ip
inject
ova
aluminum
hydroxid
adjuv
sensit
mice
challeng
ova
two
consecut
day
day
last
ova
challeng
mice
infect
subleth
dose
fig
histopatholog
analysi
lung
mice
prechalleng
ova
reveal
inflamm
limit
similar
lung
mice
prechalleng
ova
prior
viral
infect
day
postinfect
fig
left
left
middl
panel
lung
noninfect
mice
ova
challeng
ovamock
show
subtl
eosinophil
infiltr
around
bronchiol
confirm
allergen
challeng
protocol
induc
acut
allerg
airway
inflamm
fig
right
middl
panel
interestingli
mice
show
weight
loss
pb
mice
suffer
signific
weight
loss
fig
also
observ
signific
reduct
viral
titer
balf
mice
fig
proport
eosinophil
involv
acut
allerg
airway
inflamm
higher
balf
mice
ova
challeng
ovamock
mice
without
ova
challeng
pbsmock
regardless
influenza
viru
infect
day
day
infect
addit
total
cell
number
balf
mice
ova
challeng
higher
balf
mice
without
ova
challeng
infect
day
wherea
differ
number
mice
signific
regardless
influenza
viru
infect
day
fig
signific
increas
proport
neutrophil
trigger
influenza
viru
infect
observ
balf
mice
mice
day
postinfect
compar
balf
mice
without
infect
ovamock
pbsmock
respect
regardless
ova
challeng
p
vs
ovamock
p
pb
fig
taken
togeth
observ
indic
preexist
ovainduc
acut
allerg
airway
inflamm
inhibit
influenza
viru
replic
without
affect
virusinduc
inflammatori
cell
respons
earli
phase
infect
measur
amount
proinflammatori
cytokin
chemokin
balf
mice
infect
day
level
higher
ova
challeng
mice
ova
mice
without
ova
challeng
pb
fig
wherea
level
chemokin
mice
fell
day
postviru
infect
level
pb
higher
mice
fig
addit
chemokin
level
mice
without
viru
infect
day
diminish
day
postinfect
express
gmcsf
also
significantli
higher
mice
prechalleng
ova
mice
prechalleng
fig
meanwhil
level
cytokin
significantli
higher
balf
ova
mice
pb
mice
infect
day
although
declin
infect
day
regardless
viru
infect
fig
taken
togeth
result
suggest
preexist
acut
allerg
immun
respons
inhibit
replic
influenza
viru
decreas
virusinduc
cytokin
chemokin
product
reduc
sever
influenza
virusinduc
ill
compat
previou
find
two
murin
model
describ
ie
effect
allerg
airway
respons
preexist
influenza
viru
infect
fig
effect
influenza
viru
infect
preexist
acut
allerg
airway
inflamm
fig
show
conflict
result
respect
relationship
acut
allerg
airway
inflamm
influenza
viru
infect
address
reason
discrep
perform
immunohistochem
analysi
lung
tissu
use
antiinfluenza
np
antibodi
examin
distribut
viral
infect
cell
detect
similar
level
influenza
viru
antigen
bronchiolar
alveolar
epithelium
mice
day
postinfect
irrespect
subsequ
ova
challeng
fig
contrast
compar
mice
prechalleng
ova
observ
mark
reduct
amount
influenza
viru
antigen
bronchiolar
epithelium
mice
prechalleng
ova
despit
presenc
abund
infect
cell
alveolar
epithelium
fig
observ
indic
preexist
acut
allerg
airway
inflamm
suppress
influenza
viru
replic
specif
bronchiolar
airway
epithelium
site
affect
asthma
allerg
airway
inflamm
alveolar
epithelium
unaffect
asthma
allerg
airway
inflamm
thu
preexist
acut
allerg
airway
inflamm
decreas
level
virusinduc
cytokin
chemokin
product
reduc
sever
influenza
virusinduc
ill
hand
subsequ
allerg
airway
inflamm
influenza
viru
infect
lung
appear
neglig
effect
viral
replic
bronchiolar
epithelium
trigger
excess
chemokin
product
exacerb
lung
patholog
asthma
character
chronic
inflamm
bronchiol
caus
breath
difficulti
associ
airway
remodel
alter
normal
architectur
bronchiolar
wall
includ
epitheli
goblet
cell
metaplasia
subepitheli
fibrosi
thicken
bronchial
smooth
muscl
wall
histopatholog
analysi
lung
tissu
reveal
bronchiolar
epithelium
control
mice
ciliat
cuboid
stain
period
acidschiff
pa
fig
pb
true
mice
challeng
ova
day
postinfect
fig
ovachalleng
mice
infect
fig
ova
also
show
normal
bronchiolar
architectur
without
epitheli
goblet
cell
metaplasia
indic
ova
challeng
two
consecut
day
murin
model
suffici
induc
chronic
allerg
airway
reaction
airway
remodel
howev
numer
pasposit
epitheli
cell
observ
bronchiol
mice
subsequ
ovachalleng
mice
day
postinfect
fig
despit
absent
obviou
structur
chang
subepitheli
region
suggest
influenza
viru
infect
subsequ
induct
acut
allerg
airway
inflamm
promot
bronchiolar
epitheli
goblet
cell
metaplasia
pasposit
epitheli
cell
also
observ
bronchiol
mice
preexist
allerg
airway
inflamm
though
differ
number
pasposit
cell
compar
mice
statist
signific
addit
number
pasposit
cell
bronchiolar
epithelium
mice
show
low
level
viru
infect
significantli
lower
mice
fig
taken
togeth
observ
indic
influenza
viru
infect
bronchiolar
epithelium
mice
acut
allerg
airway
inflamm
promot
goblet
cell
metaplasia
airway
epithelium
without
affect
subepitheli
region
airway
accord
viral
load
neuraminidas
inhibitor
suppress
multipl
cycl
replic
influenza
b
virus
commonli
use
treat
influenza
clinic
practic
examin
effect
inhal
neuraminidas
inhibitor
influenza
virusinfectedovachalleng
mice
treat
mice
zanamivir
zan
via
rout
time
challeng
ova
repeat
two
consecut
day
postinfluenza
viru
infect
fig
note
signific
reduct
viral
titer
balf
zantreat
zan
mice
day
postinfect
compar
balf
mice
without
zan
treatment
zan
irrespect
ova
challeng
fig
addit
level
influenza
virusinfect
zantreat
mice
day
postinfect
significantli
lower
infect
mice
treat
zan
irrespect
ova
challeng
howev
level
ovachalleng
mice
infect
influenza
viru
mockova
affect
zan
treatment
fig
result
suggest
although
zan
treatment
reduc
influenza
virusinduc
inflammatori
respons
inhibit
viral
replic
effect
acut
allerg
airway
inflamm
immunohistochem
analysi
reveal
viral
antigen
bronchiolar
epithelium
influenza
virusinfect
mice
regardless
zan
treatment
day
postinfect
fig
indic
zan
treatment
murin
model
neglig
impact
influenza
viru
infect
bronchiolar
epithelium
addit
pa
stain
mice
day
postinfect
reveal
abund
goblet
cell
bronchiolar
epithelium
influenza
virusinfectedovachalleng
mice
regardless
zan
treatment
fig
observ
suggest
mild
reduct
influenza
viru
replic
treatment
antivir
drug
neuraminidas
inhibitor
suffici
prevent
bronchiolar
epitheli
metaplasia
induc
influenza
viru
infect
follow
induct
allerg
airway
inflamm
impact
allerg
airway
inflamm
upon
influenza
virusinfect
bronchiolar
epithelium
might
play
pivot
role
subsequ
epitheli
metaplasia
bronchiol
influenza
virusinfectedovachalleng
mice
asthma
complex
diseas
caus
multipl
genet
environment
paramet
close
associ
respiratori
viru
infect
clinic
epidemiolog
data
demonstr
peopl
asthma
becom
infect
influenza
viru
high
risk
hospit
admiss
elucid
pathogenesi
complic
comorbid
infecti
diseas
autoimmun
disord
import
develop
better
therapeut
prevent
anim
model
human
infecti
diseas
crucial
role
elucid
pathogenesi
diseas
similar
human
diseas
phenotyp
anim
model
phenotyp
critic
factor
elucid
pathogenesi
diseas
howev
suscept
anim
human
pathogen
differ
significantli
depend
anim
speci
strain
phenotyp
infecti
diseas
anim
model
may
differ
slightli
human
diseas
requir
care
interpret
anim
model
phenotyp
exist
murin
model
asthmainfluenza
viru
comorbid
show
seemingli
contradictori
find
model
demonstr
influenza
viru
infect
play
role
induc
asthma
develop
increas
airway
sensit
acut
phase
infect
howev
lead
signific
deterior
anim
condit
model
show
acut
allerg
airway
resist
influenza
viru
infect
influenza
viru
hinder
recruit
eosinophil
cell
airway
allergen
challeng
influenza
viru
infect
induc
respons
turn
inhibit
develop
cell
suggest
influenza
viru
infect
asthmat
reaction
oppos
effect
immun
respons
observ
appear
inconsist
epidemiolog
find
asthma
signific
risk
factor
influenza
viru
infect
contradict
prompt
us
examin
asthma
affect
influenza
viru
infect
use
novel
model
base
ncnga
mice
show
asthmat
mice
suffer
sever
lung
patholog
acut
allerg
airway
inflamm
influenza
viru
infect
interestingli
correl
exacerb
lung
patholog
viral
burden
influenza
viru
infect
injur
host
viral
replicationmedi
tissu
damag
induc
harm
inflammatori
respons
absenc
correl
viral
burden
exacerb
lung
patholog
asthmat
murin
model
suggest
exacerb
lung
patholog
observ
asthmat
mice
attribut
altern
viral
replicationmedi
tissu
damag
rather
enhanc
lung
patholog
mediat
synergist
effect
allerg
airway
inflamm
influenza
viru
infect
product
inflammatori
mediat
hypothesi
support
find
sever
inflammatori
cell
infiltr
around
airway
upregul
chemokin
lung
virusinfect
asthmat
mice
subsequ
induct
allerg
airway
inflamm
asthmat
model
mice
also
show
signific
weight
loss
influenza
viru
infect
virusinfect
mice
acut
allerg
airway
inflamm
induc
develop
less
sever
weight
loss
import
clinic
sign
deterior
assess
pathogenesi
influenza
viru
infect
mous
model
indic
influenza
viru
infect
subsequ
allerg
airway
inflamm
also
enhanc
sever
ill
addit
lung
patholog
furthermor
virusinfect
mice
acut
allerg
airway
respons
subsequ
induc
also
show
stronger
suppress
ovainduc
airway
eosinophilia
uninfect
mice
support
find
previou
report
wohllenben
et
al
show
influenza
viru
infect
inhibit
effici
recruit
cell
airway
also
import
note
find
contradict
find
report
wohllenben
et
al
whose
mice
show
weight
loss
major
differ
studi
wohllenben
et
al
exampl
former
infect
mice
viru
infect
ncnga
mice
pandem
viru
ncnga
mice
highli
sensit
sever
type
allerg
reaction
includ
atop
dermat
allerg
airway
inflamm
thu
immunopatholog
asthma
presenc
influenza
comorbid
may
differ
ncnga
mice
murin
model
clearli
show
exacerb
lung
patholog
clinic
sign
mimick
clinic
observ
human
thu
murin
model
describ
herein
may
contribut
much
understand
pathogenesi
influenza
human
asthmat
subject
moreov
wohllenben
et
al
indic
influenza
viru
infect
influenc
develop
goblet
cell
metaplasia
despit
suppress
respons
airway
remodel
major
contributor
pathogenesi
asthma
particularli
develop
airflow
obstruct
progress
declin
lung
function
airway
epitheli
cell
play
import
role
airway
remodel
associ
asthma
asthmat
patient
show
increas
number
goblet
cell
refer
goblet
cell
metaplasia
caus
prolifer
preexist
goblet
cell
rather
attribut
transdifferenti
ciliat
cell
clara
cell
goblet
cell
metaplasia
note
mild
moder
sever
form
asthma
although
find
much
common
case
sever
fatal
asthma
contrast
previou
report
influenza
virusinfect
mice
subsequ
allerg
airway
reaction
demonstr
clear
increas
goblet
cell
metaplasia
compar
infect
mice
without
subsequ
allerg
airway
reaction
uninfect
asthmat
mice
howev
mice
promin
goblet
cell
metaplasia
show
obviou
structur
chang
subepitheli
region
commonli
affect
airway
remodel
process
asthma
indic
pathogenet
mechan
goblet
cell
metaplasia
model
might
differ
convent
asthmat
airway
remodel
genet
distinguish
acut
allerg
respons
character
eosinophil
inflamm
furthermor
allergen
challeng
alon
mockova
mice
induc
goblet
cell
metaplasia
model
previou
murin
model
asthmat
airway
remodel
mice
challeng
ova
time
induc
airway
structur
chang
taken
togeth
observ
perviou
repot
suggest
ova
challeng
alon
two
consecut
day
murin
model
develop
herein
suffici
induc
convent
asthmat
airway
remodel
influenza
viru
infect
bronchiolar
epithelium
play
key
role
induc
goblet
cell
metaplasia
presenc
allerg
airway
inflamm
report
influenza
viru
infect
induc
bronchial
epitheli
regener
format
nonkeratin
stratifi
squamou
metaplasia
later
stage
infect
acut
allerg
airway
inflamm
might
skew
epitheli
regener
process
goblet
cell
metaplasia
form
squamou
metaplasia
murin
model
recent
report
indic
acut
allerg
airway
highli
resist
influenza
viru
infect
data
deriv
influenza
viru
infecti
model
subsequ
acut
allerg
airway
inflamm
contradict
find
tempor
relationship
allerg
airway
inflamm
influenza
viru
infect
report
herein
differ
report
previou
studi
previou
studi
use
model
sensit
twice
via
ip
rout
ova
day
day
infect
subleth
dose
influenza
viru
mock
infect
allanto
fluid
day
day
follow
infect
mice
administ
ova
pb
without
zan
via
rout
two
consecut
day
day
day
b
day
postinfect
viru
titer
balf
measur
plaqu
assay
micegroup
data
express
scatter
plot
mean
viral
titer
sd
p
oneway
anova
experi
repeat
twice
independ
c
concentr
balf
measur
day
postinfect
micegroup
data
express
scatter
plot
mean
sd
p
twoway
anova
experi
repeat
twice
independ
repres
section
lung
tissu
obtain
mice
treat
zan
day
postinfect
stain
influenza
viru
np
antigen
iav
np
data
repres
micegroup
two
independ
experi
origin
magnif
e
repres
passtain
section
lung
tissu
mice
treat
zan
obtain
day
postinfect
data
repres
micegroup
two
independ
experi
origin
magnif
br
bronchiol
f
number
pa
posit
epitheli
cell
lung
tissu
mice
treat
zan
day
postinfect
obtain
visual
estim
entir
area
section
data
express
scatter
plot
mean
sd
result
micegroup
two
independ
experi
p
p
twoway
anova
ovasensit
mice
infect
influenza
viru
ova
challeng
preexist
allerg
airway
inflamm
affect
immunolog
statu
lung
lead
mitig
virolog
immunopatholog
outcom
therefor
suscept
influenza
viru
infect
natur
immun
respons
would
expect
differ
subsequ
allerg
airway
inflamm
preexist
allerg
airway
inflamm
model
moreov
preexist
allerg
airway
inflamm
model
base
ncnga
mice
reveal
preexist
allerg
airway
inflamm
induc
resist
influenza
viru
infect
particularli
airway
epithelium
play
role
allerg
inflamm
data
support
report
previous
epithelium
resist
influenza
viru
infect
also
show
less
goblet
cell
metaplasia
treatment
neuraminidas
inhibitor
reduc
influenza
virusinduc
inflammatori
respons
inhibit
infect
bronchiolar
epithelium
subsequ
epitheli
metaplasia
taken
togeth
observ
also
support
hypothesi
influenza
viru
infect
play
critic
role
induc
goblet
cell
metaplasia
infect
epithelium
presenc
allerg
airway
respons
conclus
gener
character
novel
murin
model
asthma
influenza
comorbid
found
influenza
viru
infect
follow
induct
allerg
airway
respons
asthmat
mice
led
exacerb
lung
patholog
includ
pulmonari
inflamm
subsequ
epitheli
goblet
cell
metaplasia
observ
quit
consist
clinic
epidemiolog
studi
asthmat
patient
contrast
preexist
allerg
airway
inflamm
protect
subsequ
influenza
viru
infect
consist
previou
comorbid
murin
model
influenza
asthma
two
differ
outcom
murin
model
develop
herein
suggest
tempor
relat
influenza
viru
infect
allerg
airway
inflamm
might
one
determin
comorbid
influenza
viru
infect
asthmat
thu
model
develop
herein
use
investig
pathogenesi
influenza
viru
infect
human
asthma
improv
patient
care
medic
treatment
